Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease

Background: Mucosal IL-13 Receptor alpha 2 (IL13RA2) mRNA expression is one of the best predictive markers for primary non-responsiveness to infliximab therapy in patients with inflammatory bowel disease (IBD). The objective of this study was to understand how IL-13Rα2, a negative regulator of IL-13...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstockt, Bram, Perrier, Clémentine, De Hertogh, Gert, Cremer, Jonathan, Creyns, Brecht, Van Assche, Gert, Ferrante, Marc, Ceuppens, Jan L., Vermeire, Séverine, Breynaert, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305625/
https://www.ncbi.nlm.nih.gov/pubmed/30619339
http://dx.doi.org/10.3389/fimmu.2018.02983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305625/
https://www.ncbi.nlm.nih.gov/pubmed/30619339
http://dx.doi.org/10.3389/fimmu.2018.02983

Ejemplares similares